Nutex Health Inc. (NASDAQ:NUTX - Get Free Report)'s stock price dropped 5% during trading on Tuesday . The stock traded as low as $125.49 and last traded at $127.05. Approximately 41,320 shares traded hands during trading, a decline of 46% from the average daily volume of 76,534 shares. The stock had previously closed at $133.77.
Wall Street Analysts Forecast Growth
NUTX has been the topic of several analyst reports. Maxim Group upped their price target on shares of Nutex Health from $100.00 to $225.00 and gave the company a "buy" rating in a report on Tuesday, May 20th. Benchmark boosted their price objective on shares of Nutex Health from $150.00 to $300.00 and gave the company a "buy" rating in a research report on Thursday, May 15th. Finally, Wall Street Zen cut shares of Nutex Health from a "strong-buy" rating to a "buy" rating in a research report on Thursday, May 22nd.
View Our Latest Analysis on Nutex Health
Nutex Health Stock Performance
The company has a market capitalization of $633.23 million, a PE ratio of 9.58 and a beta of 0.04. The company has a current ratio of 2.27, a quick ratio of 2.26 and a debt-to-equity ratio of 1.02. The firm's 50-day simple moving average is $138.36 and its 200-day simple moving average is $80.47.
Nutex Health (NASDAQ:NUTX - Get Free Report) last released its quarterly earnings data on Tuesday, May 13th. The company reported $2.56 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.15) by $2.71. The company had revenue of $211.79 million during the quarter, compared to analysts' expectations of $81.09 million. Nutex Health had a net margin of 10.76% and a return on equity of 42.08%.
Insider Buying and Selling at Nutex Health
In other Nutex Health news, CFO Jon Christian Bates purchased 1,000 shares of the stock in a transaction dated Tuesday, April 8th. The stock was purchased at an average price of $81.81 per share, with a total value of $81,810.00. Following the transaction, the chief financial officer now owns 4,888 shares of the company's stock, valued at approximately $399,887.28. This trade represents a 25.72% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 36.92% of the stock is owned by corporate insiders.
Institutional Investors Weigh In On Nutex Health
Several hedge funds have recently modified their holdings of the business. Bank of America Corp DE lifted its position in shares of Nutex Health by 6,590.3% in the 4th quarter. Bank of America Corp DE now owns 2,074 shares of the company's stock worth $66,000 after purchasing an additional 2,043 shares during the period. OMERS ADMINISTRATION Corp lifted its position in shares of Nutex Health by 28.8% in the 1st quarter. OMERS ADMINISTRATION Corp now owns 9,400 shares of the company's stock worth $442,000 after purchasing an additional 2,100 shares during the period. Goldman Sachs Group Inc. lifted its position in shares of Nutex Health by 17.9% in the 1st quarter. Goldman Sachs Group Inc. now owns 18,119 shares of the company's stock worth $852,000 after purchasing an additional 2,748 shares during the period. Geode Capital Management LLC lifted its position in shares of Nutex Health by 12.6% in the 4th quarter. Geode Capital Management LLC now owns 34,125 shares of the company's stock worth $1,082,000 after purchasing an additional 3,826 shares during the period. Finally, Baader Bank Aktiengesellschaft lifted its position in shares of Nutex Health by 64.6% in the 1st quarter. Baader Bank Aktiengesellschaft now owns 10,700 shares of the company's stock worth $503,000 after purchasing an additional 4,200 shares during the period. Hedge funds and other institutional investors own 5.32% of the company's stock.
Nutex Health Company Profile
(
Get Free Report)
Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.
Read More
Before you consider Nutex Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutex Health wasn't on the list.
While Nutex Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.